Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 036589/0904 | |
| Pages: | 4 |
| | Recorded: | 09/17/2015 | | |
Attorney Dkt #: | 15-1045-PCT-US AND US2 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14759490
|
Filing Dt:
|
07/07/2015
|
Publication #:
|
|
Pub Dt:
|
12/03/2015
| | | | |
Title:
|
A Soluble Fibroblast Growth Factor Receptor 3 (FGR3) Polypeptide For Use In The Prevention Or Treatment Of Skeletal Growth Retardation Disorders
|
|
|
Patent #:
|
|
Issue Dt:
|
07/28/2020
|
Application #:
|
14759535
|
Filing Dt:
|
07/07/2015
|
Publication #:
|
|
Pub Dt:
|
12/10/2015
| | | | |
Title:
|
A Soluble Fibroblast Growth Factor Receptor 3 (FGR3) Polypeptide For Use In The Prevention Or Treatment Of Skeletal Growth Retardation Disorders
|
|
Assignees
|
|
|
101 RUE DE TOLBIAC |
PARIS, FRANCE F-75013 |
|
|
|
118 ROUTE DE NARBONNE |
TOULOUSE, FRANCE 31400 |
|
Correspondence name and address
|
|
MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
|
|
300 SOUTH WACKER DRIVE
|
|
SUITE #3100
|
|
CHICAGO, IL 60606
|
Search Results as of:
05/14/2024 05:35 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|